olmesartan medoxomil/amlodipine accord
accord healthcare b.v. - olmesartanas medoksomilis/amlodipinas - plėvele dengtos tabletės - 40 mg/10 mg; 20 mg/5 mg; 40 mg/5 mg - olmesartan medoxomil and amlodipine
olmesartan medoxomil/amlodipine teva
teva b.v. - olmesartanas medoksomilis/amlodipinas - plėvele dengtos tabletės - 40 mg/10 mg; 40 mg/5 mg; 20 mg/5 mg - olmesartan medoxomil and amlodipine
olmira
krka, d.d., novo mesto - olmesartanas medoksomilis/amlodipinas - plėvele dengtos tabletės - 40 mg/10 mg; 40 mg/5 mg; 20 mg/5 mg - olmesartan medoxomil and amlodipine
sanoral hct
menarini international operations luxembourg s.a. - olmesartanas medoksomilis/amlodipinas/hidrochlorotiazidas - plėvele dengtos tabletės - 40 mg/10 mg/25 mg; 40 mg/5 mg/25 mg; 40 mg/10 mg/12,5 mg; 40 mg/5 mg/12,5 mg; 20 mg/5 mg/12,5 mg - olmesartan medoxomil, amlodipine and hydrochlorothiazide
zenicamo
zentiva k.s. - kandesartano cileksetilas/amlodipinas - tabletės - 8 mg/5 mg; 16 mg/10 mg - candesartan and amlodipine
amlodipine vitabalans
vitabalans oy - amlodipinas - tabletės - 10 mg; 5 mg - amlodipine
celiprolol vitabalans
vitabalans oy - celiprololis - plėvele dengtos tabletės - 200 mg; 400 mg - celiprolol
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antinavikiniai vaistai - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
klacid sr
viatris sia - klaritromicinas - modifikuoto atpalaidavimo tabletės - 500 mg; 250 mg; 125 mg/5 ml - clarithromycin
amlodipine accord
accord healthcare b.v. - amlodipinas - tabletės - 5 mg; 10 mg - amlodipine